Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2015; Provides Revenue Guidance for 2016
For the year, the company reported revenue of $15.114 million compared to $13.277 million a year ago. Operating loss was $39.293 million compared to $36.143 million a year ago. Loss before taxation was $40.019 million compared to $35.979 million a year ago. Loss was $37.804 million compared to $34.752 million a year ago. Basic and diluted loss per ordinary share from continuing operations were of 212.9 cents compared to 238.7 cents a year ago. Net cash outflow from operating activities were of $33.796 million compared to $34.373 million a year ago. Purchase of property, plant and equipment were of $1.239 million compared to $1.481 million a year ago. Purchase of intangible assets was of $0.015 million compared to $0.266 million a year ago.
The Company expects to achieve year-over-year revenue growth in 2016 of approximately 20%.